| Wajahat Ali Khan, MD | |
|
6401 Kimball Dr, Gig Harbor, WA 98335-1228 | |
| (253) 858-9192 | |
| (253) 858-4348 |
| Full Name | Wajahat Ali Khan |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 32 Years |
| Location | 6401 Kimball Dr, Gig Harbor, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093870172 | NPI | - | NPPES |
| 0231161 | Other | WA | STATE L&I |
| 0231156 | Other | WA | STATE L&I |
| 8414021 | Medicaid | WA | |
| 0221363 | Other | WA | STATE L&I |
| 0217036 | Other | WA | STATE L&I |
| 0258715 | Other | WA | STATE L&I |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | MD00044018 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tacoma General Allenmore Hospital | Tacoma, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Multicare Health System | 7719899897 | 1704 |
News Archive
Qosina is pleased to announce that we have received ISO 13485 Certification, a globally recognized standard that specifies the requirements for a quality management system that can be used by organizations providing medical devices, components and delivery of related services.
Scientists at the Institut Pasteur and Inserm have successfully increased the infiltration of immune cells into tumors, thus inducing the immune system to block tumor growth. In an article published in Nature Immunology, the scientists show that, in combination with existing immunotherapies, this process efficiently destroys cancer cells.
A new study has been published that evaluates the benefits of VMVP by estimating the benefits of vaccination and exclusion of unvaccinated people from different settings.
The decision today by the Supreme Court will prevent millions of people from losing their health insurance, but does not stem the rising tide of visits to the nation's emergency departments or solve other problems emerging in the post-Affordable Care Act health care system, according to a statement from Dr. Michael Gerardi, president of the American College of Emergency Physicians (ACEP).
Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has formally adopted a negative opinion on the marketing authorization application (MAA) for Oncophage (vitespen) as a treatment in earlier-stage, localized renal cell carcinoma (kidney cancer).
› Verified 4 days ago
| Entity Name | Multicare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
Qosina is pleased to announce that we have received ISO 13485 Certification, a globally recognized standard that specifies the requirements for a quality management system that can be used by organizations providing medical devices, components and delivery of related services.
Scientists at the Institut Pasteur and Inserm have successfully increased the infiltration of immune cells into tumors, thus inducing the immune system to block tumor growth. In an article published in Nature Immunology, the scientists show that, in combination with existing immunotherapies, this process efficiently destroys cancer cells.
A new study has been published that evaluates the benefits of VMVP by estimating the benefits of vaccination and exclusion of unvaccinated people from different settings.
The decision today by the Supreme Court will prevent millions of people from losing their health insurance, but does not stem the rising tide of visits to the nation's emergency departments or solve other problems emerging in the post-Affordable Care Act health care system, according to a statement from Dr. Michael Gerardi, president of the American College of Emergency Physicians (ACEP).
Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has formally adopted a negative opinion on the marketing authorization application (MAA) for Oncophage (vitespen) as a treatment in earlier-stage, localized renal cell carcinoma (kidney cancer).
› Verified 4 days ago
| Entity Name | Franciscan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093165334 PECOS PAC ID: 0547173866 Enrollment ID: O20031111000789 |
News Archive
Qosina is pleased to announce that we have received ISO 13485 Certification, a globally recognized standard that specifies the requirements for a quality management system that can be used by organizations providing medical devices, components and delivery of related services.
Scientists at the Institut Pasteur and Inserm have successfully increased the infiltration of immune cells into tumors, thus inducing the immune system to block tumor growth. In an article published in Nature Immunology, the scientists show that, in combination with existing immunotherapies, this process efficiently destroys cancer cells.
A new study has been published that evaluates the benefits of VMVP by estimating the benefits of vaccination and exclusion of unvaccinated people from different settings.
The decision today by the Supreme Court will prevent millions of people from losing their health insurance, but does not stem the rising tide of visits to the nation's emergency departments or solve other problems emerging in the post-Affordable Care Act health care system, according to a statement from Dr. Michael Gerardi, president of the American College of Emergency Physicians (ACEP).
Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has formally adopted a negative opinion on the marketing authorization application (MAA) for Oncophage (vitespen) as a treatment in earlier-stage, localized renal cell carcinoma (kidney cancer).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wajahat Ali Khan, MD 6401 Kimball Dr, Gig Harbor, WA 98335-1228 Ph: (253) 858-9192 | Wajahat Ali Khan, MD 6401 Kimball Dr, Gig Harbor, WA 98335-1228 Ph: (253) 858-9192 |
News Archive
Qosina is pleased to announce that we have received ISO 13485 Certification, a globally recognized standard that specifies the requirements for a quality management system that can be used by organizations providing medical devices, components and delivery of related services.
Scientists at the Institut Pasteur and Inserm have successfully increased the infiltration of immune cells into tumors, thus inducing the immune system to block tumor growth. In an article published in Nature Immunology, the scientists show that, in combination with existing immunotherapies, this process efficiently destroys cancer cells.
A new study has been published that evaluates the benefits of VMVP by estimating the benefits of vaccination and exclusion of unvaccinated people from different settings.
The decision today by the Supreme Court will prevent millions of people from losing their health insurance, but does not stem the rising tide of visits to the nation's emergency departments or solve other problems emerging in the post-Affordable Care Act health care system, according to a statement from Dr. Michael Gerardi, president of the American College of Emergency Physicians (ACEP).
Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has formally adopted a negative opinion on the marketing authorization application (MAA) for Oncophage (vitespen) as a treatment in earlier-stage, localized renal cell carcinoma (kidney cancer).
› Verified 4 days ago
Dr. Sharon Michael, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1907 61st Ave Nw, Gig Harbor, WA 98335 Phone: 253-303-0697 | |
Dr. Keith M Weigel, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1907 61st Ave Nw, Gig Harbor, WA 98335 Phone: 253-303-0697 |